Sarepta Gains as Gene Therapy Shows Promise in Early Study

(Bloomberg) -- Sarepta Therapeutics Inc.’s experimental gene therapy for a type of muscular dystrophy benefited patients in an early-stage study, sending shares to the highest level since early Oct...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.